The Duke Cancer Institute, formerly known as the Duke Comprehensive Cancer Center, was established in 1972 and has benefited
from continuous recognition and funding from the National Cancer Institute (NCI) as one of the original 8 centers supported
by a Cancer Center Support Grant (CCSG). Over the past 38 years of NCI support, the DCI has developed into one of the largest
and most active cancer research and clinical enterprises in the world. The DCI is a single entity—the first of its kind at
Duke—that integrates and aligns patient care and basic and clinical research with the goals of improving patient outcomes,
decreasing the burden of cancer and accelerating scientific progress. To optimize discovery, development and delivery of new
treatments for cancer to patients in our community and throughout the world, the DCI is charged and empowered to serve as the
center of all activities in cancer at Duke University and Duke University Medical Center.
|
